Peer Review History
| Original SubmissionMay 31, 2024 |
|---|
|
PONE-D-24-21880Patterns of Non-Communicable Diseases Risk Factors Clustering Among Women of Reproductive Age in Nepal: Insights From a Nationally Representative Households SurveyPLOS ONE Dear Dr. Singh, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Umesh Raj Aryal, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. Additional Editor Comments: Manucript needs to revise extensively [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Title of the paper: Patterns of Non-Communicable Diseases Risk Factors Clustering Among Women of Reproductive Age in Nepal: Insights from a Nationally Representative Households Survey Reviewer’s comment: Title: Please avoid the last part of the title and just say “The patterns of clustering of non-communicable diseases risk factors among women of reproductive age in Nepal”. Abstract: Background: Please avoid using pronoun such as we, our etc. In the last sentence of the Background, avoid We aimed and say this paper aims to assess the trends of prevalence and associated factors with smoking status, overweight/obesity, and hypertension among women of reproductive age in Nepal. Methods: Replace we examined with this paper examined….. Keywords: please keep keywords in ascending order (a-z) without capitalization, separated by commas but not a semi colon. Introduction: Clarify the 41 million deaths statistics by stating complete say NCDs contribute to 41 million deaths annually worldwide; 77% of these deaths occur in Low and Middle-Income Countries (LMICs). Please Provide reference? Please choose either obese or obesity for consistency throughout the paper. Please modify the statement the National Health Education, Information, and Communication Centre (NHEICC) conducts tobacco-specific advocacy and awareness activities to “The National Health Education, Information and communication (NHEICC) leads health promotion and behaviour change communication initiatives, including tobacco-specific advocacy and awareness programs implemented through multimedia channels, public private health care facilities, media and volunteers throughout the countries”. Add references from DOHS annual report or NHEICC reports. Include additional reference related to Health promotion after reference 27. Such as: https://journals.sagepub.com/doi/full/10.1177/17579759221117792 https://www.nepjol.info/index.php/jhp/article/view/40957 Move the sentence to successfully fill this gap….., after your second last sentence and before the aims of this paper. Methods Please simplify the sentence - to identify the prevalence and significant determinants of NCD risk factors among women, this study used the NDHS 2022 data set. You can say “this study used the NDHS 2022 dataset only. Please define your final model, what does it mean and how did you determine a final model? Explanatory variables: What was the basis of categorization of each variable? please provide reference of each variable. If using exact categorization from NDHS 2022, please cite this report. Explain any changes made to variable categories. Please delete residence, which is duplicated. Please define each explanatory variable. Statistical analysis: Please keep references to support your claim after the statement “Variables with a chi-square test p-value below 0.25 were included in the multivariable models”. Start your statements with Firstly, secondly, etc, to structure your arguments. Please insert Figure 1 and 2 in the text. Overall comment: This paper is well written. However, please avoid repetition, ensure consistency throughout the document. Keep line numbers in the manuscript. A language review is also required. Reviewer #2: This was an interestknf look into patterns of Non-Communicable Diseases risk factors Clustering Among Women of Reproductive Age in Nepal. In methods: have you considered confounding factors, if so mention them In discussion: use more literature for the comparisons and compare the findings in terms of the regions or countries you find literature from Reviewer #3: Dear authors, Congratulations on writing this paper. The study analysed secondary data from NDHS 2022 to determine the prevalence of three noncommunicable diseases (NCD) risk factors in Nepalese women of reproductive age group. The study further assessed the trend in the prevalence of those risk factors from 2016 to 2022. Results showed nearly one-third of those women have at least one risk factor in Nepal. The study also reported the factors associated with the prevalence and clustering of three NCD risk factors. The overall current results will have significant impact on national policy development of developing countries. The study follows the standard guidelines for reporting cross-sectional studies. The data was analysed using appropriate statistical methods. The paper has written in standard format. However, this manuscript will be further improved for clarity and accuracy by addressing the following comments. Title The title needs to be corrected for grammar. In the title, diseases, factors, households are nouns being used as adjectives. Therefore, these would be singular. Is it two surveys or one survey? Abstract One of the objectives of the study was to assess the trends in the prevalence of risk factors. However, the results report only the prevalence rate. There are no conclusions about the trends of those risk factors. Method Though readers can find the sampling strategy in the cited documents, a brief paragraph is essential here as well. A sample size of NDHS 2016 should also be stated. Similarly, please state whether the inclusion and exclusion criteria are the same for the analysed data of NDHS 2016. Results Table 1: The indication of * to be corrected. Table 3: Please make the reference category consistent, either 1.o or ref… Please report the sample size for table 4. Data related to hypertension is different in table 1 and figure 1. Please correct or explain (N=3765 or 3749) Figure 2 is not clear about the sample. Is it NDHS 2022 or 2016? It is not clear how sample size is 3781, when analysed hypertensive participants were 3749 for NDHS 2022 as reported in method section. Discussion The first paragraph seeks the important findings of the study as specified by the overall study objectives. Data shows prevalence of clustering of risk factors was higher in women at service than those not working. Should authors need to interpret this finding? The method and strength statement suggests that the used sample was representative of the whole country. However, the authors' conclusion is restrictive (e.g These prevalence figures demonstrate a relatively higher prevalence of NCD risk factors within the studied population). Please correct. Does this increasing prevalence hold true “The increasing prevalence of smoking among older women”. The smoking trend in smoking between 2016 and 2022 is decreasing. The data was not analysed separately for the trend in older women. Please correct or explain. Conclusions The first sentence is not clear. “This study found several markers of NCD risk factors clustering among women of reproductive age in Nepal”. This sentence is to be rewritten. Based on data, women of reproductive age had a clustering of NCD risk factors. The same comment applies to the conclusions on the trends of the risk factors. General suggestion Line numbers will make the review process easier to refer to the specific line. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr Shalik Ram Dhital Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-24-21880R1Patterns of Non-Communicable Disease Risk Factor Clustering Among Women of Reproductive Age in NepalPLOS ONE Dear Dr. Singh, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR: Thank you addressing all comments. Please incorporate followingWith whom did the author compare hill janantis and dalit ? (see abstract) Please incorporate the following response in the statistical analysis section for clarity to future readers. Thanks a lot for your critical comment. As we know that, under assumption of poisson regression, mean and variance for random variable are equal, if we square the standard deviation, variance is around mean. Obviously in some cases, this assumption is violated and that was one of the reasons to choose the modified poisson regression with robust sandwich variance estimate. Moreover, mean risk factor is below 1, as this data is heavily weighted by lots of ‘zeors’ among those who do not have any NCD risk factors (approx. 64%). That’s why we didn’t interpret the mean risk factor and focused on interpreting adjusted risk ratio (ARR=i.e. ratio of count), which would be meaningful. Thank you once again for raising valid point. Please submit your revised manuscript by %DATE_REVISION_DEU%. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Umesh Raj Aryal, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Thank for addressing the comments. Please go through the feedback and incorporate them. With whom did the author compare hill janantis and dalit ? (see abstract) Please incorporate the following response in the statistical analysis section for clarity to future readers. Thanks a lot for your critical comment. As we know that, under assumption of poisson regression, mean and variance for random variable are equal, if we square the standard deviation, variance is around mean. Obviously in some cases, this assumption is violated and that was one of the reasons to choose the modified poisson regression with robust sandwich variance estimate. Moreover, mean risk factor is below 1, as this data is heavily weighted by lots of ‘zeors’ among those who do not have any NCD risk factors (approx. 64%). That’s why we didn’t interpret the mean risk factor and focused on interpreting adjusted risk ratio (ARR=i.e. ratio of count), which would be meaningful. Thank you once again for raising valid point. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Trends and determinants of clustering for non-communicable disease risk factors in women of reproductive age in Nepal PONE-D-24-21880R2 Dear Mr. Barun, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Umesh Raj Aryal, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): No further comments Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-21880R2 PLOS ONE Dear Dr. Singh, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Umesh Raj Aryal Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .